Back to articles
Research & Diagnostics
Antimicrobial resistance
Bee
Beehive
Beekeeping
Insect
Mange
Paenibacillus larvae
Queen
Vaccine
American foulbrood: Toward a Vaccine to Protect Bees
V
Vetitude
12/22/2022
3 min read
0 comments
Share:
An efficacy study shows that bees born to queens vaccinated against American foulbrood are more resistant than those from hives whose queens are not vaccinated. This vaccination is estimated to reduce the risk of bee larvae becoming infected with the bacteria by 30 to 50 percent. This is the first randomized trial of a vaccine designed for insects and marks a turning point in the management of bee diseases.
According to estimates, half of the world’s honeybee colonies are infected with the bacteria Paenibacillus larvae, the vector of American foulbrood. Vaccinating queens would reduce the risk of mortality from this disease. A new orally administered vaccine could provide transgenerational immunity, thereby increasing the resistance of bees exposed to the bacteria’s spores. The vaccine simply needs to be mixed into the food provided to the new queen before she is introduced into the hive. The vaccine is then concentrated in the bee’s fat body, the storage organ in insects. The vaccine content then binds to proteins involved in nutrient supply to the embryos, which pass it on to the eggs.
Commentaires
No comments yet.
Sign in to comment